Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Wednesday, 8th May 2024 URGN stock ended at $13.27. This is 1.34% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.75% from a day low at $13.00 to a day high of $13.49.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Sep 12, 2017 $28.20 $28.78 $27.60 $28.53 20 894
Sep 11, 2017 $28.61 $28.85 $27.57 $28.24 24 319
Sep 08, 2017 $28.84 $28.93 $27.02 $27.85 67 780
Sep 07, 2017 $27.85 $29.89 $27.29 $28.48 133 141
Sep 06, 2017 $26.00 $27.54 $25.72 $27.00 43 370
Sep 05, 2017 $25.75 $25.89 $23.79 $25.68 84 791
Sep 01, 2017 $26.75 $28.62 $23.37 $25.29 163 773
Aug 31, 2017 $24.74 $25.15 $22.95 $23.85 201 025
Aug 30, 2017 $19.73 $22.39 $19.59 $21.66 182 464
Aug 29, 2017 $18.50 $19.95 $18.18 $19.35 92 708
Aug 28, 2017 $17.87 $18.49 $17.46 $18.04 36 487
Aug 25, 2017 $17.35 $17.89 $17.28 $17.47 28 315
Aug 24, 2017 $18.05 $18.05 $17.14 $17.37 29 705
Aug 23, 2017 $17.75 $17.99 $17.42 $17.95 8 579
Aug 22, 2017 $17.32 $17.72 $17.21 $17.72 4 232
Aug 21, 2017 $17.10 $17.41 $17.10 $17.15 7 432
Aug 18, 2017 $17.45 $17.64 $17.21 $17.51 10 052
Aug 17, 2017 $17.76 $17.96 $17.47 $17.58 9 180
Aug 16, 2017 $17.69 $18.02 $17.42 $17.62 25 948
Aug 15, 2017 $17.73 $18.45 $17.51 $17.90 34 641
Aug 14, 2017 $18.00 $18.50 $17.39 $18.42 13 551
Aug 11, 2017 $17.41 $19.00 $17.35 $17.89 13 796
Aug 10, 2017 $18.05 $18.30 $17.50 $17.67 29 288
Aug 09, 2017 $18.00 $18.67 $17.40 $18.04 49 523
Aug 08, 2017 $18.71 $18.71 $18.04 $18.20 20 026
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT